Engineering chimeric antigen receptor-T cells for cancer treatment

Intratumor heterogeneity of tumor clones and an immunosuppressive microenvironment in cancer ecosystems contribute to inherent difficulties for tumor treatment. Recently, chimeric antigen receptor (CAR) T-cell therapy has been successfully applied in the treatment of B-cell malignancies, underscorin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Baixin, Stary, Creed M., Li, Xuejun, Gao, Qingping, Kang, Chunsheng, Xiong, Xiaoxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815249/
https://www.ncbi.nlm.nih.gov/pubmed/29448937
http://dx.doi.org/10.1186/s12943-018-0814-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815249/
https://www.ncbi.nlm.nih.gov/pubmed/29448937
http://dx.doi.org/10.1186/s12943-018-0814-0

Ejemplares similares